Skip to main content
OrthoVellum
Knowledge Hub

Study

  • Topics
  • MCQs
  • ISAWE
  • Operative Surgery
  • Flashcards

Company

  • About Us
  • Editorial Policy
  • Contact
  • FAQ
  • Blog

Legal

  • Terms of Service
  • Privacy Policy
  • Cookie Policy
  • Medical Disclaimer
  • Copyright & DMCA
  • Refund Policy

Support

  • Help Center
  • Accessibility
  • Report an Issue
OrthoVellum

Ā© 2026 OrthoVellum. For educational purposes only.

Not affiliated with the Royal Australasian College of Surgeons.

Oncology
intermediate
X-Type

Giant Cell Tumour Treatment

Bone Tumours

A 32-year-old woman presents with knee pain and swelling. Radiographs show an eccentric lytic lesion in the distal femoral epiphysis extending to the subchondral bone with no matrix calcification. MRI confirms a well-defined lesion with soft tissue extension through a cortical breach. Biopsy shows multinucleated giant cells in a mononuclear stromal background. Regarding giant cell tumour of bone:

Mark each as TRUE or FALSE

A

Giant cell tumour (GCT) is a locally aggressive benign tumour that typically occurs in skeletally ma...

B

The Campanacci grading system classifies GCT as: Grade I (latent - well-defined margin, intact corte...

C

GCT typically occurs before skeletal maturity in children; the diaphysis is the most common location...

D

Standard treatment for Campanacci Grade I-II is extended curettage (high-speed burr) with local adju...

E

Denosumab (RANKL inhibitor) is used for unresectable, recurrent, or metastatic GCT; it reduces giant...

Answer the questions to see explanations

Click T (True) or F (False) for each option